Prevalence of various mutations in beta thalassaemia and its association with haematological parameters

Journal of the Pakistan Medical Association

Volumn 62, Issue 1, 2012, Pages

  Khattak, Saeed Akhtar Khan ^a   Anwar, Jaleel ^a   Ahmed, Suhaib ^a   Ali, Nadir ^b   Shaikh, Kashif Hafeez ^c  

^a ARMED FORCES INSTITUTE OF PATHOLOGY   (Pakistan)

^b PNS Shifa ^*  (Pakistan)

^c PAF Hospital   (Pakistan)

Author keywords

Beta thalassaemia; Mutation and haematological values

Indexed keywords

BETA GLOBIN; HEMOGLOBIN;

ADULT; AMINO ACID SUBSTITUTION; ARTICLE; BETA THALASSEMIA; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; DNA DETERMINATION; ERYTHROCYTE COUNT; FEMALE; FRAMESHIFT MUTATION; GENE DELETION; GENE MUTATION; HEMATOLOGICAL PARAMETERS; HETEROZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEAN CORPUSCULAR HEMOGLOBIN; MULTIPLEX POLYMERASE CHAIN REACTION; MUTATION RATE; MUTATIONAL ANALYSIS; RED CELL DISTRIBUTION WIDTH;

EID: 84455203041     PISSN: 00309982     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Thein SL. Genetic modifiers of the beta-haemoglobinopathies. Br J Hematol 2008; 141: 357-66.
2. Schrier SL. Pathophysiology of thalassemia. Curr Opin Hematol 2002; 9: 123-6.
3. Thein SL. Genetic insights into the clinical diversity of b thalassaemia. Br J Hematol 2004; 124: 264-74.
4. Thein SL. Pathophysiology of b thalassemia-a guide to molecular therapies. Am Soc Hematol Educ Program 2005; 31-7.
5. Rund D, Filon D, Strauss N, Rachmilewitz EA, Oppenheim A. Mean corpuscular volume of heterozygotes for b-thalassemia correlates with the severity of mutations. Blood 1991; 79: 238-43.
6. Shen C, Jiang YM, Shi H, Liu JH, Zhou WJ, Dai QK, et al. Evaluation of indices in differentiation between iron deficiency anemia and beta-thalassemia trait for Chinese children. J Pediatr Hematol Oncol 2010; 32: 218-22.
7. Bianco I, Cappabianca MP, Foglietta E, Lerone M, Deidda G, Morlupi L, et al. Silent thalassemias: genotypes and phenotypes. Haematologica 1997; 82: 269-80.
8. Maragoudaki E, Vrettou C, Kanavakis E, Synodinos TJ, Mavrommati AM, Kattamis C. Molecular, haematological and clinical studies of a silent b-gene C-->G mutation at 6 bp 3\' to the termination codon (+1480 C-->G) in twelve Greek families. Br J Haematol 1998; 103: 45-51.
9. Maragoudaki E, Kanavakis E, Synodinos JT, Vrettou C, Tzetis M, Mavrommati AM, et al. Molecular, haematological and clinical studies of the -101 C -->T substitution in the beta-globin gene promoter in 25 beta-thalassaemia intermedia patients and 45 heterozygotes. Br J Haematol 1999; 107: 699-706.
10. Ahmed S, Petrou M, Saleem M. Molecular genetics of beta-thalassaemia in Pakistan: a basis for prenatal diagnosis. Br J Haematol 1996; 94: 476-82.
11. Garewal G, Das R, Awasthi A, Ahluwalia J, Marwaha RK. The clinical significance of the spectrum of interactions of CAP+1 (A-->C), a silent beta-globin gene mutation, with other beta-thalassemia mutations and globin gene modifiers in north Indians. Eur J Haematol 2007; 79: 417-21.
12. Khan SN, Riazuddin S. Molecular characterization of beta-thalassemia in Pakistan. Hemoglobin 1998; 22: 333-45.
13. Ahmed S, Saleem M, Modell B, Petrou M. Screening extended families for genetic haemoglobin disorders in Pakistan. N Engl J Med 2002; 347: 1162-8.
14. Ahmed S. Prenatal diagnosis of b-thalassemia: 12 years\' experience at a single laboratory in Pakistan. Prenatal diagnosis 2007; 27: 1224-7.
15. Naseem S, Ahmed S, Vahidy F. Impediments to prenatal diagnosis of beta thalassaemia: experiences from Pakistan. Prenatal Diag 2008; 28: 1116-8.
16. Premawardhena A, Fisher CA, Olivieri NF, Silva SD, Stanley JS, Wood WG, et al. A novel molecular basis for b thalassemia intermedia poses new questions about its pathopysiology. Blood 2005; 106: 3251-5.
17. Usman M, Moinuddin M, Ghani R. Molecular genetics of beta-thalassaemia syndrome in Pakistan. East Mediterr Health J 2010; 16: 972-6.
18. Varawalla NY, Old JM, Sarkar R, Venkatesan R, Weatherall DJ. The spectrum of beta-thalassaemia mutations on the Indian subcontinent: the basis for prenatal diagnosis. Br J Haematol 1991; 78: 242-7.
19. Villegas A, Ropero P, González AF, Martí E, Anguita E, De Blas JM. High incidence of the CD8/9 (+G) beta 0-thalassemia mutation in Spain. Haematologica 1998; 83: 1066-8.
20. Delledera D, Pacella E, Epifania AA, Benedetto M, Tinelli A, Mazzone E, et al. Importance of molecular biology in the characterization of beta-thalassemia carriers. Eur Rev Med Pharmacol Sci 2011; 15: 79-86.